Replies to post #11411 on Intellect Neurosciences Inc. (fka ILNS)

[James salmon]

There are lots of companies out there with much weaker pipelines that trade significantly higher that ILNS current share price. To me it's just that there has been no news, no updates and we really have no idea what is going on. I believe that this is all due to the current court case, when that is over I expect news to start flowing.

[itwillgetbetter]

Nope.Its a valid point and its good to have a real discussion.If ILNS had a FDA approved drug which they had the patents on with license agreements with big pharma the pps would be 5,10 bucks or higher and the float would be 1/3 of what it is.

Its very rare almost impossible for a tiny company like ILNS to ever be allowed to get to be a mid player like VPHM.

First they sold the licenses way back way to cheap.Who new top tier companies would spend billions to go forward and billions more will continue to be spent.

I say thats why the defendants wanted to seal the dollar amount,ect.That one and only transcript says alot.You paid to much or we did not pay enough and that will never happen again.Ha Ha

I think they got to greedy in 2011 and could have sold the company then.

If you don't think Pfizer other top tier companies don't have on payroll ones that investigate what they are ask one needs to rethink that.

Pfizer new Intellect's position.They new just when to strike at there weakest point.They new everything we new/know and 10 times more imho.